Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial
Overview
- Phase
- Phase 2
- Intervention
- Resin-modified glass ionomer cement Clinpro XT
- Conditions
- Dentin Hypersensitivity
- Sponsor
- Federal University of Pelotas
- Enrollment
- 20
- Primary Endpoint
- Pain Scores as measured by the Visual Analog Scale (VAS)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.
Detailed Description
Subjects will require to have at least two teeth in different hemiarchs with dentin hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline), painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.
Investigators
Rafael Guerra Lund
Associate Professor
Federal University of Pelotas
Eligibility Criteria
Inclusion Criteria
- •Male and female subjects between 18 and 70 years old
- •At least 2 teeth with dentin hypersensitivity in two different hemiarchs
- •Dental elements with hypersensitivity without any pulp alteration
- •People who are not taking any medication and women who are not pregnant
- •Patients without eating disorders or very acidic diets.
Exclusion Criteria
- •Teeth with hypersensitivity that presented extensive or unsatisfactory restorations, fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, pulp alterations.
- •Subjects who received any desensitizing therapy during the last 3 months
- •Subjects being under analgesics/anti-inflammatory drugs at the time of the study
- •Teeth with hypersensitivity and non-carious cervical lesions
Arms & Interventions
Clinpro XT (3M ESPE, Minnesota, USA)
Resin-modified glass ionomer cement
Intervention: Resin-modified glass ionomer cement Clinpro XT
Vidrion R (SS White, Gloucester, UK)
Conventional glass ionomer cement
Intervention: Glass Ionomer cement Vidrion R
Outcomes
Primary Outcomes
Pain Scores as measured by the Visual Analog Scale (VAS)
Time Frame: Change from Baseline in Pain Scores at 20 minutes; at 7, 15, 21, 30 days; and after 3, 6, 12, 24 months.
Tactile and air blast tests to evaluate pain with VAS